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Executive Summary
Food labels embody a range of attributes: a salad 
bag may be “organic," a yogurt may be "low fat," 
and potato chips may be "all natural." Each year, 
food companies create new and innovative labels to 
market their products. In 2008 in the United 
States, 22,566 new food products were introduced 
to the market. More than 100,000 types of food 
products line the shelves of supermarkets and 
wholesale stores [Economic Research Service, 
USDA 2009c], With so many different foods and 
labels, how do consumers make choices, and who 
ensures that these labels are trustworthy and help­
ful to consumers? The U.S. government created the 
Food and Drug Administration [FDA], a regulatory 
agency "responsible for assuring that foods sold in 
the United States are safe, wholesome, and 
properly labeled" [FDA 2008], The FDA works 
with Congress, the United States Department of 
Agriculture [USDA], the Environmental Protection 
Agency [EPA], and other governing bodies to set 
food-labeling standards. The FDA does not pre­
approve labels but has the right to request changes 
or removal of labels that do not meet its specifica­
tions. Therefore, food manufacturers have some 
freedom in labeling and can work creatively to pro­
vide consumers with the information needed to 
make purchasing decisions (FDA 2008],
Opinion polls in the early 2000s suggested that 
the majority of U.S. consumers want to know if 
their food products contain genetically modified 
material. GMOs, or genetically modified organisms, 
are the result of gene transfer technology. They are 
used in agriculture to create plants with traits that 
are desirable to farmers, consumers, or other food 
system parties. The United States has no govern­
ment-sponsored food-labeling schemes that state 
whether or not food products contain GM 
material. Government regulations do, however, 
prohibit the presence of genetically engineered 
material in food that carries the government- 
approved label assuring that food is produced using 
organic production processes. Thus, consumers 
who wish to avoid GM material can buy organic 
food. Another option for consumers who do not 
want to buy food that may contain GMOs is to 
select foods labeled "GMO-free." Such labeling is
organized by civil society groups and food com­
panies. To carry the label, foods must comply with 
standards set by the organizers. The government 
does not regulate the label but may intervene if 
there is evidence that the label is misleading. A new 
initiative for voluntary labeling of "GMO-free" 
food raises the question of what role—if any—the 
government should play in monitoring and imple­
menting labeling related to GMOs.
Your assignment is to advise the U.S. government 
on whether it should engage in the labeling of 
GMO or GMO-free foods or monitor voluntary 
labeling organized by the private sector and civil 
society, and if so, how it should proceed. Would 
you give the same advice to a developing country? 
If not, how would it differ?
Background
The Issue
in 2007, 91 percent of soybeans, 87 percent of 
cotton, and 73 percent of corn grown in the 
United States contained genetically engineered 
material. Yet most Americans do not know 
whether the products they consume contain 
GMOs. According to federal regulation, organic 
crops cannot be produced using biotechnology. 
Certain groups, however, would like to give con­
sumers the option of choosing GMO-free food 
items that may not be organically produced. One 
such group is the Non-GMO Project. With the 
motto "Working together to ensure the sustained 
availability of non-GMO food and products," the 
Project has spearheaded an initiative to place a non- 
GMO label on foods that do not contain GM 
material (Figure I]. The Project will allow manu­
facturers to voluntarily label foods with the non- 
GMO label if the product has undergone specific 
testing to assure that it does not contain more 
than 0.9 percent GM material (Non-GMO Project 
2009b],
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Although the initiative may be helpful to 
consumers, it confronts a much larger issue. First, 
attitudes toward GMOs in foods vary. A t one end 
of the spectrum, many farmers, food manu­
facturers, and consumers believe that GMOs are 
beneficial to humankind and warranted by the 
improvements in production and food availability. 
A t the other end, some are wary of GMOs and 
concerned about potential effects on the biosafety 
of the food supply, human health, and the 
environment. Some nongovernmental organizations 
[NGOs] argue that GMOs are a private sector ploy 
that create dependence on private companies and 
fail to improve food availability and access in devel­
oping countries. The Non-GMO Project initiative 
may exacerbate public controversy and force the 
government to take a proactive role in support of 
or opposition to GMOs, or at least their labeling. 
Second, the debate raises questions about the con­
stitutionality of labeling requirements and the 
accountability of the government. In the 1990s, the 
FDA stated that foods produced by biotechnology 
are not "substantially" different from foods 
produced by traditional breeding. Therefore, the 
FDA uses the same framework to investigate and 
regulate products made using biotechnology as it 
does foods produced through traditional breeding. 
Differences in safety or nutritional status are 
addressed during review of the final GMO food 
product, not the process. Likewise, the FDA has no 
labeling policies that separately address GMOs, and 
a new policy may be contentious, as well as time 
consuming and costly. It would require accurate 
tracking of foods and transfer of information along 
the supply chain. Third, the Non-GMO Project
challenges the efficacy of government intervention. 
Because the Project encourages voluntary labeling 
by the private sector, it concerns the role of the 
private sector and other stakeholders who may find 
benefit or detriment in the labeling debate. 
Government intervention may or may not be effec­
tive or necessary.
History of Genetic Engineering
The process of genetic engineering is grounded in 
the fundamentals of genetics. In 1866 Gregor 
Mendel published his paper "Experiments on Plant 
Hybrids" on the basic principles of genetics, the 
science of heredity. He hypothesized that observa­
ble traits are based on units called genes. Today, a 
gene is recognized as a region of DNA that 
encodes a specific RNA or protein. Mendel, an avid 
plant breeder, applied his research to agriculture, 
manipulating genes by mating various plants with a 
high probability of achieving a desired result. As 
farmers became educated about Mendelian genetics, 
they too selectively bred their plants. This primary 
advancement, used in conjunction with primary 
farming techniques, raised crop yields and increased 
food availability [Hartwell et ai. 2008].
In the 1970s, geneticists made another revolu­
tionary advance when they began cutting and 
splicing DNA molecules. This gene manipulation, 
called recombinant DNA technology, allows scien­
tists to combine DNA molecules of different 
origins [Hartwell et al. 2008]. They can move a 
gene from one organism to another of the same 
species, move a gene from one organism to
another across species, or alter genes within an 
organism. Such alteration may include "shutting 
off" or activating "silent" genes to change physical 
properties, chemical properties, or both [Pinstrup- 
Andersen and Schioler 2000).
Recombinant DNA technology laid the ground­
work for biotechnology, a field of science that 
encompasses all production of altered organisms by 
use of biological systems. Further advances allowed 
scientists to manipulate a variety of genes, making 
biotechnology a routine branch of research 
[Hartwell et al. 2008). In the 1980s and 1990s, bio­
technology quickly became a part of agricultural, 
pharmaceutical, and other industries. In 1983, the 
National Institutes of Health (NIH) approved the 
first release of GMOs out of the lab and into test 
fields. This GMO was a bacterium that could be 
used to prevent frost damage on strawberries. 
Debate followed the approval. In 1992, Calgene Inc. 
produced the first commercial GMO food: the 
Flavr Savr tomato had the ideal property of delayed 
ripening. Therefore, the crop had a longer shelf life 
and farmers had fewer shipping constraints. The 
FDA conducted a review of the Flavr Savr tomato 
and concluded that it was "substantially equivalent" 
to non-GMO tomatoes in terms of nutritional 
value, composition, and safety [Mackenzie 2000).
Today, many GM crops and foods have desirable 
attributes that farmers might not be able to achieve 
using traditional plant breeding. Beneficial agro­
nomic traits include herbicide resistance, insect 
resistance, delayed ripening, viral resistance, oil 
modification, fertility restoration, and male sterility. 
Farmers generally view these traits as having a posi­
tive effect on the environment, especially since 
insecticide resistance decreases the need for pesti­
cides. For example, corn and cotton have been 
genetically engineered to produce Bt, Bacillus 
thuringiensis, a protein that is lethal to insects. 
About one-third of the corn produced in the 
United States contains Bt. Furthermore, genetically 
modified quality traits include nutrient fortification, 
improved flavor, and preservation. "Golden rice," 
genetically engineered rice that contains beta- 
carotene, is an example of nutrient fortification, 
and anti-freeze strawberries, which can withstand 
harsh weather, are an example of delayed ripening. 
Both of these products are currently being studied 
and are not yet approved for consumer purchase.
The traits developed through biotechnology are 
seen as yielding health and environmental benefits, 
but they also generate biosafety concerns. For 
example, because Bt is lethal to insects, some con­
sumers are concerned that it may be toxic to 
human health. There are no scientifically proven 
negative health effects, but biotechnology is young, 
and it is possible that studies of short-term effects 
may not show long-term effects [Parekh 2004).
In addition to the positive or negative environ­
mental and health effects, GM crops have an 
important economic impact. According to a recent 
study, biotechnology increased crop production by 
3.9 million tons, lowered crop production costs by 
US$1.9 billion, and increased growers' net returns 
by US$2.6 billion in the United States in 2006. 
Biotechnology crops included alfalfa, canola, corn, 
cotton, papaya, soybean, squash, and sweet corn 
[NCFAP 2008).
Mandatory Food-Labeling Policies and 
Regulation in the United States
Food labels in the United States come in an array 
of colors, shapes, and designs that aim to attract 
consumer attention and help consumers make 
informed food choices. Regulating food labels 
became a government responsibility in 1938 upon 
passage of the Food, Drug, and Cosmetic Act 
[FDCA). Section 403 of this act states that the 
food label must include four components: the 
ingredients used to make the food; net weight of 
the food; the name and address of the manu­
facturer, packer, or distributor; and the identity or 
name of the food. Section 201 [n] of the FDCA 
gives the FDA the right to require more informa­
tion on food labels to help consumers make food 
choices. For example, foods containing wheat must 
declare the presence of gluten to warn consumers 
with celiac disease of the food contents [Weirich 
2007).
It was not until 1990 that Congress required the 
nutritional information currently on food labels. It 
amended the FDCA and created the Nutritional 
Labeling Education Act [NLEA). Similar to the 
FDCA, the goal of the NLEA was to communicate 
meaningful information in a clear and understanda­
ble manner. It required food manufacturers to dis­
close essential nutritional information [serving size, 
calories, fat, protein, cholesterol, carbohydrate) 
that consumers needed to make prudent food
choices. The NLEA is based upon the notion of 
"essentiality"; it requires only the information that 
is needed to allow consumers to make prudent 
food choices [Weirich 2007],
In the 1990s, Congress became increasingly aware 
of concerns about biotechnology. The issue was 
consigned to the FDA, the USDA, and the EPA, 
which today remain the main regulatory institu­
tions for biotechnology. In 1992, the FDA pub­
lished a Statement of Policy on GM foods. It con­
cluded that there is no meaningful difference 
between bioengineered food and other foods so 
the "key factors in reviewing safety concerns 
should be the characteristics of the food product, 
rather than the fact that the new methods are 
used." Therefore, it follows the same principles to 
regulate foods produced through biotechnology as 
it does for foods produced by traditional breeding 
methods. It regulates the products, not the process 
[FDA 1992).
With regard to labeling, the FDA requires that GM 
food be labeled if it poses safety risks, contains 
properties that are not found in the food before 
modification, or contains significantly different 
nutritional properties. For example, a tomato 
injected with a peanut protein can no longer be 
called a common "tomato" because it may cause an 
unsafe, allergic reaction in some consumers [FDA 
1992). The FDA makes case-by-case decisions about 
foods containing GMOs and maintains its policy 
that labels should contain only the most basic, 
pertinent information unless instructed otherwise 
by the terms of section 201 [n] of the FDCA. 
Congress has reviewed bills that propose labeling 
goods containing GMOs, but none has passed into 
law [Mackenzie 2000).
The most recent attempt to pass such a law is the 
Genetically Engineered Food Right to Know Act, 
proposed to the House of Representatives in May 
2006. The purpose of the act was "to amend the 
Federal Food, Drug, and Cosmetic Act, the Federal 
Meat Inspection Act, and the Poultry Products 
Inspection Act to require that food that contains a 
genetically engineered material, or that is produced 
with a genetically engineered material, be labeled 
accordingly." The act proposed specific labeling 
requirements and periodic testing of foods by the 
FDA to ensure compliance. The requirements ex­
cluded food served for immediate human consump­
tion, such as that in restaurants, and medical foods.
The bill was presented to several subcommittees in 
the House. It never became law [U.S. Congress 
House 2006).
Voluntary Food Labeling Policies and 
Regulations in the United States
Although U.S. government institutions regulate the 
labeling of consumer goods in the United States, 
there is a fair amount of freedom in labeling. Not 
only do manufacturers have the opportunity to 
decide on their marketed design and image, but 
they can voluntarily label foods to indicate the 
presence or absence of bioengineered foods. In 
January 2001, the FDA published a document called 
Guidance fo r Industry: Voluntary Labeling Indi­
cating Whether Foods Have o r Have N o t Been 
Developed Using Bioengineering. The publication 
offered only "draft guidance," and it was issued for 
the purpose of eliciting comment. Still, this docu­
ment represented FDA policy and set the ground­
work for voluntary labeling. Its main purpose was 
to recognize that private manufacturers may label 
their foods that contain or do not contain bio­
engineered material and to provide suggestions for 
the most informative and least misleading labeling 
statements. The FDA does not set standards that 
the labels must meet, although it does have the 
authority to intervene once labels are on the 
market [FDA 2001).
Voluntary labeling efforts also exist outside the 
scope of bioengineered foods. For example, the 
Smart Choices program was an initiative to give 
manufacturers the option of placing a "smart 
choice" label on their foods. If a food meets certain 
requirements, set by the private Smart Choices 
program, the manufacturer can place the seal of 
approval on the front of the food label. The mis­
sion of the program is to "help shoppers make 
smarter food and beverage choices" [Smart Choices 
Program 2009). Although the program seems help­
ful and is fully endorsed by many of the largest 
food manufacturers, controversy has arisen because 
foods with a high content of sugar and fat, such as 
Fruit Loops, mayonnaise, Lunchables, and Teddy 
Grahams, may be labeled "smart choices." The 
directors of the Smart Choices program claim that 
the standards are based on FDA recommendations, 
but consumers and health professionals are wary of 
a marketing scheme that they believe displays mis­
leading information. The FDA has decided to 
intervene and address the concern. It is analyzing
the consumer response and public health effects of 
the labeling initiative to ensure that consumers 
receive accurate information. The FDA may choose 
to clarify the standards, create a new standard, 
support or prohibit the program, do nothing, or 
endorse a combination of actions [Neuman 2009b).
Policy Issues
Public A w areness and  A cceptance of GM Os
As already noted, there is no consensus in the U.S. 
population regarding the use of genetic engineering 
in food production. On the one hand, some are 
concerned about the biosafety issues—especially 
allergens, toxins, and environmental and ecological 
impacts—associated with GMO products. On the 
other hand, some people support GMO products 
for their advantages, particularly decreased insecti­
cide use and higher crop yields. This group argues 
that virtually all breeding techniques, including 
what are normally referred to as "traditional 
breeding techniques," have potentially deleterious 
effects [Bruhn 2003). Survey results suggest that a 
large percentage of the U.S. population does not 
substantially understand biotechnology. This lack of 
understanding often results from a lack of educa­
tion and exposure to biotechnology and general 
science [Priest 2000).
In 2000, the Public Policy Research Institute at 
Texas ASM  University conducted a nationwide 
telephone survey to ask U.S. citizens about their 
opinions on biotechnology. The study found that 
as a whole, a little more than half of the U.S.
Table 1: G lo b a l Survey o f  A ttitu d e s
tow ard G M O s____________________




United States 37 55
Canada 31 63





Source: Pew Research Center for the People 
and the Press 2003.
population held a positive view of biotechnology. 
When asked whether "biotechnology will provide 
benefits" in the next five years, 59 percent of 
interviewees responded positively. When asked if 
biotechnology would "improve our way of life in 
the next 20 years," 52.8 percent responded 
positively [Priest 2000).
The Public Policy Research Institute found that the 
U.S. population has confidence in science and agri­
culture, but not in government regulators. Support 
for biotechnology was less, however, than support 
for other technologies such as the Internet or 
space exploration, and opposition to biotechnology 
proved to be generally higher than for other tech­
nologies. Support for biotechnology has decreased 
in the past five years. This decline may be a result 
of government regulation or media attention, 
which highlights the potential risks of biotech­
nology [Priest 2000).
In a global study conducted by the Pew Research 
Center for the People and the Press, 37 percent of 
Americans said that genetically modified fruits and 
vegetables are good, 55 percent said they are bad, 
and 8 percent did not know [Table 1). Of the seven 
economically advanced countries surveyed, Ameri­
cans held the least negative view. Countries with 
the most negative views included France, with 89 
percent of the surveyed group responding that 
scientifically altered fruits and vegetables were bad, 
Germany, at 81 percent, and Japan, at 76 percent. 
The study also found that women held a more 
negative view of GMO food than men [Table 2).
Table 2: M en 's and W om en's A ttitu d e s  
tow ard G M O s
Men Less Negative about 
Genetically Modified Foods
Believe G M O s Men Women Diff.
are bad % %
United States 52 73 21
Canada 57 73 16
Great Britain 47 62 15
Japan 69 82 13
Italy 75 85 10
Germany 86 91 5
France 74 74 0
Source: Pew Research Center for the People and the 
Press 2003.
A study by Rutgers University's Food Policy Insti­
tute based on a representative sample of 1,203 
Americans found that 90 percent of those sur­
veyed were in favor of mandatory labeling of GM 
foods. Moreover, 74 percent believed that strict 
regulation of genetically modified products is 
necessary and 73 percent agreed that “most geneti­
cally modified foods were made by scientists 
because they were able to make them, and not 
because the public necessarily wanted them" 
[Hallman et al. 2002, 29). According to this poll, 
the American public wants the right to know 
whether their foods contain GMOs. A paradox 
arises, however, when they are asked about their 
purchasing habits. Only 45 percent expressed a 
willingness to pay more for non-GMO foods, and 
only 53 percent said they would take the time to 
look for non-GMO foods. Therefore, it seems that 
most Americans believe that they have too little 
information to make an informed consumption 
decision, but it is unclear whether they are willing 
to use this information and spend time or money 
to change their diet and habits. Possibly this issue is 
one of perceived control over their purchasing and 
eating power. Similarly, 48 percent of the surveyed 
public said they would be less likely to purchase 
fruits and vegetables that were advertised to con­
tain GMOs; 37 percent said it would make no dif­
ference in their purchasing decisions; II percent said 
they would be more likely to buy GMO products; 
and I percent were unsure [Hallman et al. 2002).
The strong demand for labeling of genetically engi­
neered foods found in the Rutgers University 
study was confirmed by a survey conducted by the 
Center for Science in the Public Interest, which 
found that 70 percent of respondents wanted 
foods containing genetically engineered ingredients 
to be labeled as such. Seventy-six percent of 
respondents wanted foods that had been sprayed 
with pesticides to be labeled, and 65 percent 
wanted food from plants treated with plant 
hormones to be labeled. The survey also included 
the following question: "If you had a choice 
between two boxes of Wheaties, where the label on 
one box indicated that it contains genetically engi­
neered ingredients and the label on the other box 
indicated that it does not contain genetically engi­
neered ingredients, which would you choose, or 
would you not care?" Eight percent responded 
"Labeled 'Contains genetically engineered ingre­
dients,'" 52 percent responded "Labeled 'Does not 
contain genetically engineered ingredients,"' 38
percent responded "Would not care," and 3 per­
cent responded "Don't know" [CSPI 2001).
Another paradox of the labeling debate is that the 
biopharmaceutical industry uses the same principles 
of bioengineering to produce pharmaceuticals for 
medicinal purposes but does not receive the same 
public opposition. Some examples of products in­
clude Herceptin produced by Genentech to fight 
breast cancer, and Enbrel, produced by Amgen to 
fight autoimmune diseases such as rheumatoid 
arthritis [Parekh 2004). One reason for the differ­
ing public opinion may be the perceived need. 
Most people believe they need pharmaceuticals to 
cure their illness or problem. For example, if a 
woman is diagnosed with breast cancer and given 
Herceptin by her doctor, she will likely not ques­
tion whether genetic engineering was used to 
develop the drug if it avoids the progression of 
cancer. A mother whose children suffer from 
hunger is equally unlikely to say no to maize which 
will alleviate the hunger whether it is produced with 
genetically modified seed or not.
Nonetheless, acceptance of genetically modified 
food took an unexpected twist during a hunger 
crisis in 2002, when Malawi, Mozambique, Zambia, 
and Zimbabwe rejected U.S. food aid over GM 
content. Pro-GM groups criticized these countries' 
governments for putting millions at risk of starva­
tion, while the governments and anti-GM groups 
cited the unknown long-term health effects of GM 
food. Since then, GM crops have gained considera­
ble acceptance in Africa, but none of these coun­
tries produce GM food [Zerbe 2004). Reasons for 
the relative lack of trust in GM food may include 
perceived lack of benefit, lack of control, lack of 
trust of the biotech industry, or involuntary 
exposure when consuming GM food.
The Role of Government in Labeling
The FDA has stated that the goal of labeling food 
products is to provide clear, necessary, and infor­
mative communication to the consumer. Therefore, 
the government must decide on its responsibility in 
labeling biotechnology, as well as in determining 
consumer rights and regulating the private sector. 
As noted, the Public Policy Research Institute 
found that the American public does not have con­
fidence in the U.S. government on the issue of GM 
food. Studies show that consumers want more 
knowledge, but it is unclear whether labeling is an
effective way to restore consumer confidence 
[Hallman et al. 2002],
Furthermore, the survey results raise the issue of 
whether labels should include other information 
about agricultural practices. If the government is 
responsible for providing information about 
GMOs, should it also be responsible for informing 
consumers about the use of pesticides? Whether 
inorganic fertilizers or manure was used on the 
fields where the food is produced? And the coun­
try of origin? Labeling requirements can spiral out 
of control, and the government may become 
responsible for labeling a multitude of charac­
teristics. Furthermore, the biotechnology labeling 
debate has created significant tension between the 
private and public sectors. As seen with the Smart 
Choices Program, a lack of communication between 
the two parties can also allow private sector initia­
tives to spiral out of control. A t the same time,
other initiatives, such as the certified organic food 
program, have been hugely successful. Therefore, 
the government must first decide on its role in 
labeling and then decide on the role of the private 
sector in self-policing its own standards.
International G M O  Labeling Policies: The 
Global Debate
The amount of genetically engineered crops pro­
duced worldwide has increased steadily in the past 
12 years. In 2008, global hectarage hit 125 million 
and the number of countries that produce GM 
crops increased to 25. Significant increases were 
also evident in the number of farmers who cultivate 
GM crops and in the types of GM crops grown. In 
2008, the United States was the leading producer 
of genetically engineered crops, producing on ap­
proximately 62.5 million hectares [Figure 2].
Figure 2: Biotech Crop Countries and Mega-Countries, 2008______
Biolech Crop Countries and Mega-Counirics*, 2008
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Argentina, with 21 million hectares in 2008, was 
the second-largest producer of biotechnology 
crops—mainly maize, cotton, and soybeans. The 
Argentine government regulates bioengineered 
material on the basis of product rather than 
process. It monitors products on a case-by-case 
basis in compliance with its GMO-specific legisla­
tion. Biosafety, including concerns about the threat 
to public health and hazards to the environment, is 
given the greatest attention when crops are 
examined for approval by Argentina's National 
Advisory Committee on Agricultural Biosafety 
[Parekh 2004],
China was the sixth-Iargest producer of biotech­
nology crops in 2008. Next to the United States, 
China produces the most diverse collection of GM 
crops, including cotton, tomatoes, poplars, 
petunias, papayas, and sweet peppers. The most 
widely produced crop is Bt cotton, which has 
resulted in large economic gains, especially for the 
7.1 million small and resource-poor farmers who 
have adopted it. A study by the Center for Chinese 
Agricultural Policy concluded that on average these 
farmers increased their yields by 9.6 percent and 
generated an increase in income of US$220 a 
hectare in 2008. Pesticide use fell by approximately 
60 percent, resulting in environmental and health 
benefits [ISAAA 2008],
Demand for approval of GM seeds, including 
genetically modified rice, has surged in China. Dr. 
Dafang Huang, former director of the Biotech­
nology Research Institute of the Chinese Academy 
of Agricultural Sciences [CAAS] concluded, "Using 
GM rice is the only way to meet the growing food 
demand" [ISAAA 2008], On November 27, 2009, 
China approved GM Bt rice and GM phytase maize 
for commercial planting. According to ISAAA 
[2009], GM rice can generate benefits of US$4 
billion a year for up to 110 million Chinese house­
holds growing 30 million hectares of rice. Assum­
ing four people per family, the beneficiaries would 
total 440 million. This approval not only will 
improve quality of life and sustainability, but also 
may represent a turning point for worldwide 
acceptance of GM foods [ISAAA 2009],
Until 2008, South Africa was the only producer of 
biotechnology crops in Africa. The country began 
producing GM crops in 1996 and has emerged as 
the eighth-largest producer, planting 1.8 billion 
hectares in 2008. The most widely produced GM
and traditionally produced crop in the country is 
maize. Today, South Africa is no longer the only 
producer of biotechnology crops in Africa. In 
2008 Burkina Faso introduced Bt cotton and Egypt 
introduced Bt maize. In Kenya approval of GM 
crops is pending.
The 26 countries shown in Figure 2 represent 40 
percent of the global population. About 1.3 billion 
people in Argentina, Brazil, China, India, and South 
Africa depend on agriculture. Perhaps the strongest 
argument in favor of GMO foods is the need to 
expand food production to meet demand and sup­
port small and resource-poor farmers. Application 
of biotechnology can help reduce food insecurity 
and poverty and prevent excessive food price 
increases [ISAAA 2008],
The European Union seems most reluctant to 
adopt biotechnology, although 7 of the 27 member 
countries planted more than 100,000 hectares in 
2008 [ISAAA 2008], The EU first approved GM 
food in 1995, but a de facto moratorium in 1998 
restricted imports. It was not until 2004 that the 
European Commission lifted the moratorium and 
reapproved the import of GM products for use in 
animal feed and for human consumption [Gross- 
man 2005], In contrast to the United States, the 
EU approves GM foods based on the process 
rather than the product. The European Commis­
sion thus considers that there is a material differ­
ence between GM foods and foods produced by 
traditional breeding. The EU also has stringent 
labeling guidelines for foods that contain biotech 
material. If a food product contains at least 0.9 
percent GMO material, the label must explicitly 
state "This product contains genetically modified 
organisms." This threshold allows for "adventitious 
or technically unavoidable" GM material. EU mem­
ber countries are responsible for complying with 
this rule [Weirich 2007],
Stakeholders
Fanners
Farmers are the source of genetically modified food 
and perhaps the primary stakeholder group af­
fected by the labeling debate. GM crops in the 
United States cover 57.7 million hectares. ISAAA 
studies report that the farm income gain from bio­
technology in agriculture from 1996 to 2006 was 
US$15.9 billion Games 2007], Herbicide-resistant
plants have resulted in expanded use of one herbi­
cide, glyphosate, and reduced use of other 
herbicides, while insect-resistant plants have 
resulted in reduced use of insecticides. The use of 
herbicide has facilitated minimum tillage practices, 
which, in turn, has reduced the emission of green­
house gases from the soil and tractors. Because of 
the large economic benefits to farmers, adoption of 
genetically modified crops has increased steadily 
since it was first introduced in 1996 [Figure 3], This 
stakeholder group is generally against the labeling 
of GMO and non-GMO foods because of concern 
that such labeling would reduce the demand for 
GM crops [Economic Research Service, USDA 
2009a],
Organic Farmers
Organic farming is expanding at a rapid rate in the 
United States. In 2008, there were 1,030 organic 
products approved and on the market. The organic 
production process follows specific certification 
standards implemented by the USDA's National 
Organic Program. Under these standards, an agri­
cultural product can be labeled "organic" or "100
percent organic" if it contains 95 percent organic 
ingredients; a processed product can be labeled 
"made with organic ingredients" if it is made from 
at least 70 percent organic ingredients. The 
standards also stipulate that certified organic crops 
cannot contain any genetically modified material 
[USDA 2008]. Generally, organic farmers are op­
posed to the use of genetic modification in agri­
culture for at least two reasons. First, cross-pollina­
tion may introduce GM elements into plants pro­
duced under organic conditions and thus contami­
nate the organic food, which must not contain 
such elements. Second, many farmers who are dedi­
cated to organic production methods share many 
consumers' belief that genetic engineering is 
unnatural and bad for the environment. The 
majority of organic farmers could be expected to 
be proponents of labeling GMO and non-GMO 
foods because such labeling may create a negative 
connotation for GMO products and result in 
increased demand for organic products. On the 
other hand, the availability of foods labeled as con­
taining no genetically modified components might 
compete with organically produced food.
Figure 3: Growth o f G M  crops in  the United States, 1996-2009 
Rapid growth in adoption of genetically engineered crops continues in the U.S.
Percent of acres
Source: Economic Research Service, USDA 2009a.
Agribusiness
The term "agribusiness" includes "all the activities 
that take place in the production, manufacturing, 
distribution, wholesale and retail sales of an agri­
cultural commodity" [Cameron 2006, 4], As a 
whole, agribusiness accounts for 20 percent of U.S. 
gross domestic product [Cameron 2006], Accord­
ing to the Food and Agriculture Organization of 
the United Nations [FAO], agribusiness brings 
"farm to fork." Agribusiness can have a large 
impact on the U.S. food supply and economy, and 
companies must follow strict guidelines to assure 
consumer safety, product quality, and environ­
mental protection [FAO 2010],
One of the largest companies in the seed business 
is Monsanto. The company was founded in 1901 in 
the United States when it launched the production 
of saccharine. It is now a global agribusiness com­
pany and producer of genetically altered seed with 
traits such as yield potential, herbicide resistance, 
insect resistance, and drought tolerance. The com­
pany's value statement says, "We apply innovation 
and technology to help farmers around the world 
produce more while conserving more. We help 
farmers grow yield sustainably so they can be suc­
cessful, produce healthier foods, better animal 
feeds and more fiber, while also reducing agricul­
ture's impact on our environment." The company 
suggests that farmers should use biotechnology to 
decrease pesticide use and greenhouse emissions, 
increase yield, and improve quality of life for 
farmers in developing countries. Monsanto, 
employing the phrase "it's all about yield," boasted 
net sales of US$8.3 billion and net income of 
US$993 million in 2007. In 2008, net sales 
increased by 36 percent to US$11.3 billion and net 
income increased 104 percent to US$2 billion. 
Analysts forecast continued growth for the com­
pany and estimate that gross profit in 2012 will be 
US$9.5 billion—nearly 2.5 times greater than the 
2007 gross profit of US$4.2 billion. Such financial 
success is a result of increased farmer demand, 
acquisitions, new technology, and global expansion 
(Monsanto 2009],
Created in 2000, Syngenta is another global agri­
business company that produces seed and crop 
protection. According to its website, the company 
is "committed to sustainable agriculture...through 
innovative research and new technology" and built 
upon the vision of meeting global food demand. 
Like Monsanto, Syngenta reports significant profits.
In 2008, it reported net sales of US$11.6 billion, a 
gross profit of US$5.7 billion, and net income of 
US$1.8 billion (Syngenta 2009], Other large agri­
business companies that use biotechnology include 
Pioneer (DuPont], Prodigene, and Epicyte.
These agribusinesses have had huge success and 
seem to be growing, but they have faced significant 
opposition because of their market power, resulting 
in part from the monopoly positions created by 
seed patenting. For example, the Organic Con­
sumers Association has launched the "Millions 
against Monsanto" campaign [OCA 2009], Like­
wise, the transnational NGO Greenpeace targets 
Monsanto for poor corporate governance and 
argues that it has used toxic operations in the past 
and is now trying to avoid responsibility. Green­
peace states, "Monsanto is putting GE foods on 
the market without concern for the potential 
health or environmental risks" [Greenpeace 2009],
Monsanto, Syngenta, and other agribusiness com­
panies do not support labeling. They claim that 
their products are just as safe for consumers as 
non-GMO products. They support the FDA's 
present policy of not regulating genetically 
modified food based on process and of labeling 
specific products only if they pose a public health 
concern or contain an allergen or different nutri­
tional property.
Supermarkets
The Non-GMO Project reports that 80 percent of 
processed foods in supermarkets contain GM 
material. Most retailers, however, have little control 
over whether or not they are selling products that 
contain GMOs. Often, supermarkets are unaware 
of whether they are selling GM products (Non- 
GMO Project 2009b],
The Non-GMO Project asks for retail support, re­
questing that supermarkets endorse the Project and 
give donations. Whole Foods Market, New Leaf 
Community Markets, and more than 100 other 
supermarkets have made a commitment to the 
Project and offered donations. Large supermarkets 
such as Safeway, Wal-mart, and Kroger, however, 
have not publicly endorsed the Project (Non-GMO 
Project 2009c],
In 2009, supermarkets became the key stake­
holders in the country-of-origin labeling [COOL] 
debate. Congress decided to mandate country-of-
origin labeling in the Farm Security and Rural In­
vestment Act [Farm Bill] to inform consumers 
where all food products originated [Economic 
Research Service, USDA 2009b], The bill requires 
food retailers to include statements such as "Prod­
uct of U.S.A." or "Imported from Mexico" when 
selling produce, meat, or fish. Like the GM debate, 
the COOL debate emerged from the demand for 
mandatory labeling but faces increased criticism. 
Proponents argue that consumers have the right to 
know the source of their foods while opponents 
argue that the costs outweigh the benefits. The 
Agricultural Marketing Service [AMS], which is 
part of the USDA, estimated that the direct costs 
of country-of-origin labeling would be between 
US$582 million and US$3.9 billion [Krissoff et al. 
2004],
The N on-G M O  Project and O ther Advocacy 
Coalitions
The Non-GMO Project is a nonprofit organization 
that addresses the concern about GM foods. It 
advocates for voluntary labeling of food products 
that do not contain GMOs and prides itself on 
third-party verification. Its website reads, "Our 
shared belief is that everyone deserves an informed 
choice about whether or not to consume geneti­
cally modified products, and our common mission 
is to ensure the sustained availability of non-GMO 
choices." The Project encourages manufacturers to 
place a "Non-GMO" seal on food labels if the food 
meets specific standards. The seal is a butterfly on 
two blades of grass in the form of a checkmark 
[Figure 1], The Non-GMO Project does not 
promise that the final products that display the seal 
are 100 percent GMO-free. Rather, it promises 
that the process for producing such foods used 
ingredients with less than 0.9 percent GMO and 
relied on best practices to avoid contamination. 
The program is process-based, and manufacturers 
are responsible for using the best practices to 
maintain the standards. The Non-GMO Project 
does not report on how frequently it monitors 
products with the seal.
The Non-GMO Project also prides itself on col­
laboration and support from consumers, retailers, 
and manufacturers alike. In 2009, 421 retailers 
endorsed the seal, including large retail chains such 
as Whole Foods Market. The Project approved 
1,430 products produced by 66 different manu­
facturing companies. Consumers have also taken 
the Non-GMO "pledge." The Project has more
than 140 "followers" on Twitter and more than 
3,500 "fans" on Facebook [Non-GMO Project 
2009],
Other advocacy groups that endorse labeling in­
clude the Consumers Union, the Organic and Non- 
GMO Report, the Institute for Responsible Tech­
nology, and the Center for Food Safety. Several 
other advocacy groups exist.
Consumers
Most polls of the U.S. population suggest that a 
majority of consumers want the right to know if 
GMO ingredients are present in their food. The 
paradox of labeling, however, is that although con­
sumers report wanting this information, they will 
not spend the money or time to assure that they 
are consuming GMO-free foods. Policy makers 
have the responsibility of taking action when the 
consumer right to know goes too far or causes a 
decrease in economic profitability. It is unclear 
whether consumer spending will compensate regu­
lators, along with farmers and food manufacturers, 
for their labeling efforts [Hallman et al. 2002], 
Likewise, it is important to note that consumers do 
not show such disapproval for the biopharma- 
ceutical industry. The FDA has approved many bio­
technology health care and medicinal products with 
little public objection [Parekh 2004],
U.S. Governm ent
In the United States, the FDA and USDA are the 
principal regulatory bodies involved in food 
labeling. Congress has mandated labeling regula­
tions but may delegate rules and responsibility to 
the FDA. The functions and positions of the FDA 
and USDA have already been described.
U.S. Trading Partners
The World Trade Organization is a global organiza­
tion whose "goal is to help producers of goods and 
services, exporters, and importers conduct their 
business" [WTO 2009], The United States joined 
the WTO upon the founding of the organization 
on January 1, 1995. Currently the United States 
trades thousands of food products with member 
countries and serves as the headquarters for many 
global food manufacturers (WTO 2009], WTO 
member countries have their own labeling policies 
for food products based on differing government 
legislation and public demands. Some argue that 
there should be an international, harmonized label
to standardize product quality, improve global 
communication, and remove trade barriers, but at 
present such a label does not exist.
International labeling policies for food products 
that contain GMOs differ because countries use 
and regulate these products differently. Therefore, 
the decision to label or not label may have implica­
tions for international trade of GMO or non- 
GMO products [Jansen and Lince de Faria 2002], 
In particular, the United States and the European 
Union differ in their GMO labeling and trading 
policies. In 2003, the United States, joined by 
Argentina and Canada, filed a complaint with the 
WTO about the EU restrictions, claiming that the 
EU moratorium banning the import of GM foods 
was not consistent with WTO policies. The United 
States argued that the moratorium violated the 
Sanitary and Phytosanitary [SPS] Agreement of the 
WTO because it was not backed by scientific evi­
dence and assessment. The SPS Agreement spells 
out the WTO's policy on protecting human health 
without restricting trade. It states that "any sanitary 
or phytosanitary measure is applied only to the 
extent necessary to protect human, animal, or plant 
life or health, is based on scientific principles, and is 
not maintained without sufficient scientific evi­
dence" [WTO 1994, Article 2.2], EU member states 
removed the moratorium in 2004, but some re­
strictions remain [Grossman 2005], The WTO 
works with the Codex Alimentarius Commission in 
Rome, the World Health Organization, and the 
FAO to address labeling policies [Codex Alimenta­
rius Commission 2010],
If the United States decides to embark on a policy 
of mandatory or voluntary labeling, trade barriers 
might be diminished and markets may open up, 
even outside of the European Union. On the other 
hand, the postharvest costs of separating GM and 
non-GM commodities are likely to increase, and 
labeling might complicate matters if it interferes 
with the global demand and economic profitability 
of foods containing GMOs (Weirich 2007).
Health Advocates and Environmentalists
Health advocates represent two sides of the story. 
On one side are those who believe that GMO 
material should be removed from the food supply 
because of potentially negative but scientifically 
unproven human health effects. On the other side 
are those who believe that GMO material is neces­
sary because it increases the global food supply;
reduces poverty, hunger, and malnutrition; pro­
vides an opportunity for the removal of toxins and 
allergens; and reduces health risks associated with 
the application of chemical pesticides. Because of 
the high-profile nature of GMOs, the issue has 
received significant mainstream publicity. Writers 
such as Marion Nestle and Michael Pollan and films 
such as Food Inc. have voiced opinions about the 
issue of GMOs in foods.
Opponents of GM food argue that food impurity, 
allergenicity, and potential toxicity are hard and 
fast reasons to label. Consumers with a history of 
allergies and dietary limitations are particularly con­
tentious. They believe that inadvertent production 
of allergens and changes to nutritional properties 
may not be noticed by manufacturers and govern­
mental food regulators, or not noticed as a health 
concern until after harm to human health has 
occurred. They also argue that because pest- 
resistant genetically modified crops are toxic to 
insects, they may also be toxic to humans. Even if 
GM foods only pose a small risk, this stakeholder 
group does not want to assume this risk at all. 
Therefore, these health advocates believe that food 
producers and the government have an ethical 
obligation to label food products that contain GM 
material [Weirich 2007],
A different group of health advocates believes that 
biotechnology is beneficial because it helps to feed 
a hungry world. They argue that money should not 
be spent on giving high-income individuals, such as 
those in the United States, the right to choose GM 
or non-GM foods when resource-poor individuals, 
especially those in the developing world, face the 
choice of whether to eat GM foods or suffer from 
malnutrition. Why would the United States want to 
label and risk decreased production of GM foods if 
it is part of the solution to global hunger, poverty, 
and malnutrition [Pinstrup-Andersen and Schioler 
2000)?
Environmentalists are similarly torn over the issue. 
One group believes that the use of genetic 
engineering promotes environmentally damaging 
monocultures and contamination of organic crops 
with genetic material [Weirich 2007). Others argue 
that biotechnology is advantageous because it 
decreases pesticide use and greenhouse gas emis­
sions. Pesticides kill innocent insects and artificially 
disrupt the ecosystem [Pinstrup-Andersen and
Schioler 2000], In 2006, biotechnology reduced 
pesticide use by 55,000 tons [NCFAP 2008],
Policy Options
Various options are available to the U.S. federal 
government. Four are mentioned here.
The U.S. G overnm ent Does N othing
The easiest and cheapest solution to the labeling 
debate may be for the federal government to do 
nothing. It would maintain its current policies, 
rules, regulations, and practices. It would continue 
to base mandatory labeling on product differences 
and public health concerns rather than on produc­
tion processes. Along with government inaction, 
the private sector may choose to do nothing to 
avoid confusing, non-standardized labels. Pro­
ponents of this option argue that extra labeling is 
not cost-effective and may result in an increase in 
the cost of food. Opponents argue that consumers 
have the right to know what they are eating and 
should not be forced to accept the government's 
failure to act.
If the private sector chooses to label voluntarily, 
the FDA would have the power to require label 
changes under FDCA Section 201 [n]. Self-policing 
by the private sector may result in a lack of 
standard, consistent information, but it could also 
result in consumer knowledge and choice. If an 
organization such as the Non-GMO Project leads 
the effort for voluntary labeling, this organization 
would conduct initial examination of food 
products. The voluntary label could be a seal or a 
statement that reads "Contains genetically modified 
organisms," "Does not contain genetically modified 
organisms," or a similar phrase. This label could be 
placed anywhere on the food package: on the 
front, on the back, in the ingredient list, or in the 
nutritional facts. The biggest issues with this option 
concern the credibility and effectiveness of the 
label. The trustworthiness of the Non-GMO 
Project or other advocacy organizations, consumer 
interpretation of the label, and compliance by 
agribusiness are other considerations.
The U.S. G overnm ent Implements a 
Mandatory N on-G M O  Label
The government could choose to implement a 
policy that sets specifications and requires manda­
tory labeling of foods claimed to be GMO-free.
Such a policy could appease consumers without 
attaching a negative connotation to foods that con­
tain GM material. It could make farmers more 
inclined to adopt non-GMO practices, and food 
companies could gain profits if they penetrate a 
new market for non-GMO crops. A manufacturer 
could even use the label as a marketing tool to 
identify itself as a health or environmental leader. 
The government would regulate and monitor the 
use of the label.
Opponents of labeling argue that a government 
policy is pointless because organic food already 
offers assurance of non-GMO food and the FDA 
allows voluntary labeling of non-GMO food. GM- 
specific policies will add extra cost, time, and effort 
to food manufacturing because products will re­
quire tracking from seed to shelf and careful 
segregation between GM and non-GMO products 
or continual testing along the food chain. To 
achieve this segregation of products, farmers and 
manufacturers may require new equipment,
storage, and practices. The government would need 
to identify a stakeholder group, third party, or 
itself to be accountable for tracking or testing to 
maintain the integrity of the non-GMO label. Op­
ponents also argue that GM labeling will crowd 
more "meaningful" information or might not even 
fit on the package. The Non-GMO Project has set 
a threshold of 0.9 percent GM material to be con­
sidered GMO-free. The U.S. government may or 
may not agree with this standard.
The government might choose to implement this 
labeling policy alone or in conjunction with a pro­
gram to educate consumers about the meaning of 
the label. Such an education program could close 
the gap between consumers who say they want 
GMO labeling and those who say they will actually 
use GMO labeling to make purchasing decisions. It 
might also help to avoid misinterpretation and 
spread of inaccurate information. An education 
campaign might be costly, however, and would not 
ascertain consumer satisfaction or action to pur­
chase non-GMO material.
The U.S. Governm ent Requires G M O  Labeling
The U.S. government could create a policy to 
mandate labels on foods that contain GMO 
material, similar to the proposed Genetically Engi­
neered Right to Know Act. The government would 
set specific standards and monitor the use of the 
label. The policy might apply to foods that contain
more than the EU threshold of 0.9 percent GM 
material or another specific percentage. The label 
might be a seal, written statement, or other form 
of message to consumers that the food contains 
GM material.
The advantage of this option is that consumers 
would be given the right to know. Yet one concern 
about the GMO label is the tone; it may be inter­
preted as a warning to  consumers. Another issue is 
the extent of the label. The label may be put on 
processed foods and unprocessed fruits and vege­
tables that contain GMOs. It could also be placed 
on meats that come from animals that consumed 
feed containing GMOs. If this is the case, animal 
feed must also be labeled. As with a non-GMO 
policy, regulators would need to  determine a way 
to distinguish GMO from non-GMO products 
through product segregation, supply chain track­
ing, or continual testing and then label products 
accordingly.
To clarify the purpose and explain which foods are 
labeled, the government may choose to add an 
education component to its labeling policy. The 
government could require food companies to label 
foods that contain GMOs and inform consumers 
about the meaning of the label. This approach 
could increase public awareness about the GMO 
issue and influence public perception. Yet, as with a 
non-GMO education campaign, the potential mar­
ket response is unclear. If an education campaign 
reduces consumer confusion and fear, it might 
increase economic gains. There is no guarantee, 
however, that such a campaign would be effective 
or that the food industry would be fully compen­
sated for its efforts. A  campaign would add costs 
and responsibilities to the government and to the 
entire food industry.
The U.S. G overnm ent Creates a Pro-GM O or  
A nti-G M O  Campaign
The U.S. government, agribusiness, or civil society 
could implement a pro-GMO or anti-GMO cam­
paign to advocate for the presence or absence of 
GM material in foods. The campaign could inform 
consumers about the benefits or risks and even 
provide incentives for purchasing or not purchas­
ing foods that contain genetically engineered 
material. The campaign might disseminate or 
exacerbate negative connotations about GM food. 
Such campaigns would achieve their goals only if 
consumers are given the option to execute their
choice—that is, through some kind of labeling. A  
campaign could significantly influence the U.S. 
population and the food industry, but it would 
have to be backed with scientific evidence to  avoid 
opposition and criticism from those who disagree.
Assignment
Your assignment is to advise the U.S. government 
on whether it should engage in the labeling of 
GMO or GMO-free foods or monitor voluntary 
labeling organized by the private sector and civil 
society, and if so, how it should proceed. Would 
you give the same advice to a developing country? 
If not, how would it differ?
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